CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
San Diego, California, United States and 8 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
San Diego, California, United States and 226 other locations
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...
Phase 1
La Jolla, California, United States and 35 other locations
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...
San Diego, California, United States and 5 other locations
Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...
San Diego, California, United States and 10 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Encinitas, California, United States and 446 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
San Diego, California, United States and 23 other locations
OKI-219-101 is a Phase 1a/1b, open-label, multicenter, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), ph...
Phase 1
Encinitas, California, United States and 25 other locations
This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...
Phase 3
San Diego, California, United States and 163 other locations
The purpose of this trial is to inform the future clinical development of the two investigational agents in ER+ breast cancer, LEE0...
Phase 1, Phase 2
San Diego, California, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal